Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease ; volume:8 ; number:1 ; day:5 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (5.8.2022), 1-7, 12.2022
- Urheber
-
Tezuka, Toshiki
Taniguchi, Daisuke
Sano, Mariko
Shimada, Tomoyo
Oji, Yutaka
Tsunemi, Taiji
Ikeda, Aya
Li, Yuanzhe
Yoshino, Hiroyo
Ogata, Jun
Shiba-Fukushima, Kahori
Funayama, Manabu
Nishioka, Kenya
Imai, Yuzuru
Hattori, Nobutaka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-022-00367-y
- URN
-
urn:nbn:de:101:1-2022102019210707744907
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tezuka, Toshiki
- Taniguchi, Daisuke
- Sano, Mariko
- Shimada, Tomoyo
- Oji, Yutaka
- Tsunemi, Taiji
- Ikeda, Aya
- Li, Yuanzhe
- Yoshino, Hiroyo
- Ogata, Jun
- Shiba-Fukushima, Kahori
- Funayama, Manabu
- Nishioka, Kenya
- Imai, Yuzuru
- Hattori, Nobutaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models